| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2021 | 1 | 0 | 13F-HR | 11/12/2021 | 000095015921000314 | |
| Q2 2021 | 1 | 0 | 13F-HR | 8/13/2021 | 000095015921000226 | |
| Q1 2021 | 8 | 14,719 | DIS, MCO, MSFT, V | 13F-HR | 5/14/2021 | 000095015921000148 |
| Q4 2020 | 53 | 71,228 | CZR, DIS, SEAS, ENPH | 13F-HR | 2/12/2021 | 000095015921000076 |
| Q3 2020 | 14 | 65,815 | AAPL, CZR, SEAS, MA | 13F-HR | 11/13/2020 | 000095015920000240 |
| Q2 2020 | 16 | 91,321 | AAPL, IAC, CZR, TCO | 13F-HR | 8/13/2020 | 000095015920000190 |
| Q1 2020 | 16 | 233,701 | WBC, CY, AGN, TIF | 13F-HR | 5/14/2020 | 000095015920000123 |
| Q4 2019 | 11 | 138,303 | WCG, WBC, MDCO, AGN | 13F-HR | 2/13/2020 | 000095015920000044 |
| Q3 2019 | 10 | 120,215 | WCG, WBC, VSM, AGN | 13F-HR | 11/13/2019 | 000156761919021152 |
| Q2 2019 | 9 | 189,366 | WBC, WP, VSM, RHT | 13F-HR | 8/13/2019 | 000156761919016430 |
| Q1 2019 | 3 | 85,326 | VSM, WBC, RHT | 13F-HR | 5/14/2019 | 000156761919010673 |
| Q4 2018 | 3 | 38,142 | SHPG, TRCO, RHT | 13F-HR | 2/13/2019 | 000156761919003655 |
| Q3 2018 | 2 | 32,074 | SHPG, NXPI | 13F-HR | 11/13/2018 | 000156761918005762 |
| Q2 2018 | 3 | 134,113 | NXPI, FCE.A, SHPG | 13F-HR | 8/13/2018 | 000156761918000557 |
| Q1 2018 | 4 | 193,448 | NXPI, MON, DST, NVDA puts | 13F-HR | 5/14/2018 | 000114036118023268 |
| Q4 2017 | 1 | 75,718 | NXPI | 13F-HR | 2/13/2018 | 000114036118006868 |
| Q3 2017 | 1 | 73,132 | NXPI | 13F-HR | 11/13/2017 | 000114036117041975 |
| Q2 2017 | 1 | 70,778 | NXPI | 13F-HR | 8/11/2017 | 000114036117031361 |
| Q1 2017 | 9 | 237,517 | GLOBAL BLOOD THERAPEEUTICS IN, KATE, CBF, NXPI | 13F-HR | 5/12/2017 | 000114036117019914 |
| Q4 2016 | 6 | 64,383 | NXPI, RAD, WGL, ICPT | 13F-HR | 2/13/2017 | 000114036117006116 |